Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects

Huberman Lab

Scicomm Media

Science, Health & Fitness, Life Sciences

4.8 • 26.2K Ratings

🗓️ 11 September 2023

⏱️ 141 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In this journal club episode, my guest is Stanford and Johns Hopkins-trained physician, Dr. Peter Attia, M.D., who is also the host of The Drive podcast and the author of the bestselling book "Outlive: The Science & Art of Longevity." We each present a scientific paper and discuss the findings' strengths, weaknesses and actionable takeaways. First, we discuss an article that addresses whether taking the drug metformin can enhance longevity. Then, we discuss an article on belief effects (similar to placebo effects), showing how the effects of a drug on the brain and cognition depend on one's belief about the dose of the drug taken, not the actual dose. Our conversation also highlights how to read, interpret and critique scientific studies. This episode ought to be of interest to those curious about health and longevity, medicine and psychology and for anyone seeking to better understand how to read and digest scientific findings. For the full show notes, including articles, books, and other resources, visit hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Helix Sleep: https://helixsleep.com/huberman Levels: https://levels.link/huberman InsideTracker: https://insidetracker.com/huberman Momentous: https://livemomentous.com/huberman Timestamps 00:00:00 Dr. Peter Attia, Journal Club 00:03:27 Sponsors: Helix Sleep & Levels 00:06:11 Dreams 00:12:36 Article #1, Metformin, Mitochondria, Blood Glucose 00:19:47 Type 2 Diabetes & Causes, Insulin Resistance 00:25:30 Type 2 Diabetes Medications, Metformin, Geroprotection, Bannister Study 00:36:19 Sponsor: AG1 00:37:15 TAME Trial; Demographics, Twin Cohort 00:44:27 Metformin & Mortality Rate 00:51:28 Kaplan-Meier Mortality Curve, Error Bars & Significance, Statistical Power 01:01:17 Sponsor: InsideTracker 01:02:23 Hazard Ratios, Censoring 01:09:00 Metformin Advantage?, Variables, Interventions Testing Program 01:16:02 Berberine, Acarbose, SGLT2 Inhibitors 01:23:48 Blood Glucose & Energy Balance; Caloric Restriction, Aging Biomarkers 01:32:22 Tool: Reading Journal Articles, 4 Questions, Supplemental Information 01:38:10 Article #2, Belief Effects vs. Placebo Effect 01:45:22 Nicotine Effects 01:51:07 Nicotine Doses & Belief Effects, fMRI Scan 02:00:07 Biological Effects, Dose-Dependent Response & Belief Effects 02:05:14 Biology & Beliefs, Significance, Dopamine Response, Non-Smokers 02:10:57 Dose-Dependence & Beliefs, Side Effects, Nocebo Effect 02:19:06 Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous, Neural Network Newsletter, Social Media Title Card Photo Credit: Mike Blabac Disclaimer

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to the Huberman Lab podcast where we discuss science and science-based tools for everyday life.
0:08.6	I'm Andrew Huberman, and I'm a professor of neurobiology and
0:12.2	Ophthalmology at Stanford School of Medicine. Today marks the first journal club episode
0:17.5	between myself and Dr. Peter Atiyah. For any of you that are not familiar with Dr. Peter Atiyah,
0:22.7	he is a medical doctor and MD who is an expert in all aspects of health and lifespan.
0:28.6	He's the author of a best-selling book entitled Outlive, which is a phenomenal resource on all things health-span and lifespan.
0:35.1	And he is the host of the very popular podcast The Drive, where he interviews various experts in all domains of medicine and
0:43.6	scientists as well. Today Peter and I hold our first online collaborative journal club. For those of you that aren't familiar with what a journal club is,
0:51.2	a journal club is a common practice in graduate school and or medical school,
0:55.0	whereby students get together to discuss one or two papers to critique those papers and to really compare their own
1:01.4	conclusions of those papers with the conclusions of the authors and to highlight any key takeaways.
1:06.5	Peter and I have been wanting to do a journal club together for a very long time, and we decided to do that journal club and to record it for you.
1:14.3	So today you will be sitting in on the first Huberman Atiyah journal club.
1:18.9	By the way, it could just have easily been called the Atiyah Huberman Journal Club.
1:23.2	And we will discuss two papers.
1:25.1	First, Peter is going to discuss a paper on Metformin, which is a drug that many people are interested in for its potential role in longevity.
1:33.9	I want to highlight potential there.
1:35.8	He's going to compare that paper to previous findings on Metformin.
1:39.8	And by the end of that discussion, he will advise us to whether or not he himself would take Metformin and whether or not other people might be well advised or ill advised to take
1:49.5	Metformin based on the data in that paper and at this time.
1:53.5	Then I present a paper, which is about the placebo effect.
1:56.8	I have to imagine that most of you have heard of the placebo effect.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Scicomm Media, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Scicomm Media and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.